NCT00341614

Brief Summary

Type 2 diabetics (non-insulin-dependent) are more than five times as likely to suffer an initial myocardial infarction (MI; heart attack) compared to nondiabetics.Female diabetics in particular, have a higher mortality rate for coronary artery disease (CAD) than male diabetics.C-reactive protein measurement in the clinical setting enhances the detection of individuals who are at high risk for cardiovascular disease (CVD), by providing additional predictive value. We propose to study the effects of a supervised exercise and diet intervention on cardiovascular disease risk in postmenopausal diabetic women. We will recruit 35 postmenopausal, sedentary type 2 diabetics who will undergo a 3 month exercise and dietary intervention. They will exercise 3 times a week for 30 min in a supervised setting. Exercise mode will be aerobic and self-selected (i.e. treadmill, bike) at an intensity level of 50-85% VO2peak. Blood glucose will be monitored before and after exercise. The dietary intervention will consist of 6 meetings with a registered dietitian. The study is designed to test the following hypotheses:

  • Cardiovascular disease risk measures will be different following a 3-month exercise and diet intervention.
  • H1: Blood markers for coronary artery disease risk, as measured by CRP, TC, LDL, TG, FG, fasting insulin, and HbA1c, will be different following a 3-month exercise and diet intervention.
  • H2: Anthropometric measures of coronary artery disease risk, as measured by WHR, will be different following a 3-month exercise and diet intervention.
  • H3: Resting blood pressure, as measured by SBP and DBP, will be different following a 3-month exercise and diet intervention.
  • H4: Total body fat, as measured by DXA, will be different following a 3-month exercise and diet intervention.
  • Health-related measures will be different following a 3-month exercise and diet intervention.
  • H1: Cardiorespiratory fitness, as measured by maximal oxygen consumption (VO2max) will be different following a 3-month exercise and diet intervention.
  • H2: Bone-mineral density, as measured by DXA, will be different following a 3-month exercise and diet intervention.
  • H3: Dietary measures (total daily kcal, and daily fat kcal) will be different following a 3-month exercise and diet intervention.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
35

participants targeted

Target at P50-P75 for phase_1 cardiovascular-diseases

Timeline
Completed

Started Jun 2006

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

June 1, 2006

Completed
18 days until next milestone

First Submitted

Initial submission to the registry

June 19, 2006

Completed
2 days until next milestone

First Posted

Study publicly available on registry

June 21, 2006

Completed
10 months until next milestone

Study Completion

Last participant's last visit for all outcomes

May 1, 2007

Completed
Last Updated

August 16, 2007

Status Verified

August 1, 2007

First QC Date

June 19, 2006

Last Update Submit

August 14, 2007

Conditions

Keywords

ExerciseDiabetes Mellitus, Type 2PostmenopauseDiet

Outcome Measures

Primary Outcomes (10)

  • VO2max at 3 months

    3 months

  • C-reactive protein at 3 months

    3 months

  • Blood lipids (total cholesterol, LDL, HDL, TC/HDL ratio, triglycerides) at 3 months

    3 months

  • Fasting glucose at 3 months

    3 months

  • Fasting insulin (insulin resistance) at 3 months

    3 months

  • HbA1C at 3 months

    3 months

  • Body fat % at 3 months

    3 months

  • Blood pressure (SBP, DBP) at 3 months

    3 months

  • Waist-hip ratio at 3 months

    3 months

  • Total kcal and fat kcal at 3 months

    3 months

Secondary Outcomes (1)

  • Bone-mineral density at 3 months

    3 months

Interventions

Eligibility Criteria

Age45 Years - 75 Years
Sexfemale
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Female 45-75 yrs old
  • Type 2 diabetic for \> 6 months
  • "Reasonable" control of diabetes
  • blood glucose within 100-250 mg/dl prior to exercise
  • absence of hypoglycemic symptoms
  • diabetes control verified by physician
  • cleared by physician to begin exercise program
  • Postmenopausal \> 6 months
  • Sedentary
  • Ability and willingness of patient to give written, informed consent
  • Able and willing to participate in an exercise intervention

You may not qualify if:

  • Diabetes not in control
  • unable to maintain blood glucose within 100-250 mg/dl
  • development of urinary ketone bodies (ketosis)
  • symptoms of hypoglycemia before, during, and post-exercise
  • no physician's approval to participate
  • Male
  • Female \<45 or \>75 yr
  • \> 300 lb (weight limit for DXA table)
  • On insulin
  • Contraindications to Exercise Testing (ACSM, 2000)
  • Ischemia
  • Recent myocardial infarction
  • Unstable angina
  • Uncontrolled cardiac arrhythmias
  • Severe aortic stenosis
  • +11 more criteria

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of California, San Francisco

San Francisco, California, 94143, United States

Location

MeSH Terms

Conditions

Cardiovascular DiseasesDiabetes Mellitus, Type 2Motor Activity

Interventions

ExerciseNutrition Assessment

Condition Hierarchy (Ancestors)

Diabetes MellitusGlucose Metabolism DisordersMetabolic DiseasesNutritional and Metabolic DiseasesEndocrine System DiseasesBehavior

Intervention Hierarchy (Ancestors)

Motor ActivityMovementMusculoskeletal Physiological PhenomenaMusculoskeletal and Neural Physiological PhenomenaData CollectionEpidemiologic MethodsInvestigative TechniquesHealth Care Evaluation MechanismsQuality of Health CareHealth Care Quality, Access, and EvaluationEpidemiologic MeasurementsPublic HealthEnvironment and Public Health

Study Officials

  • Deborah Sellmeyer, M.D.

    University of California, San Francisco

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
phase 1
Allocation
NON RANDOMIZED
Masking
NONE
Purpose
PREVENTION
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER

Study Record Dates

First Submitted

June 19, 2006

First Posted

June 21, 2006

Study Start

June 1, 2006

Study Completion

May 1, 2007

Last Updated

August 16, 2007

Record last verified: 2007-08

Locations